ARCHIVES

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

This article is from The Cancer Letter archive.

Vol. 01 No. 24 | July 19, 1974

Download PDF Visit The Full Archive

Related Articles

Study Supports Hypothesis On Mastectomy Timing

June 7, 1991

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.

May 26, 2006

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011